half year results 2006 contents highlights 1 financial 2 business 3 operating review 10 consolidated income statement 15 balance sheet 17 cash flow 18 of recognised and expense 19 independent report to astrazeneca plc 20 notes the interim statements 21 information for us investors 31 shareholder 33 cautionary regarding forward looking in order utilise safe harbour provisions private securities litigation reform act 1995 we are providing following these contain certain about although believe our expectations based on reasonable assumptions any may be influenced by factors that could cause actual outcomes materially different from those predicted identify using words anticipates believes expects intends similar expressions such subject numerous risks uncertainties important differ contained which beyond control include among other things loss or expiration patents marketing exclusivity
